Abstract
Cancer stem cells are subsets of tumor cells defined through the capacity to initiate tumors and have been linked to therapeutic resistance. In this issue of Cell Stem Cell, Todaro et al. (2007) demonstrate that targeting tumor IL-4 sensitizes colon cancer stem cells to chemotherapy.
MeSH terms
-
Animals
-
Antineoplastic Agents / pharmacology
-
Cell Death / drug effects
-
Colonic Neoplasms / pathology
-
Fluorouracil / pharmacology
-
Humans
-
Interleukin-4 / biosynthesis
-
Mice
-
Neoplastic Stem Cells / drug effects
-
Neoplastic Stem Cells / pathology*
-
Organoplatinum Compounds / pharmacology
-
Oxaliplatin
-
Receptors, Interleukin-4 / metabolism
Substances
-
Antineoplastic Agents
-
Organoplatinum Compounds
-
Receptors, Interleukin-4
-
Oxaliplatin
-
Interleukin-4
-
Fluorouracil